Skip to site content

National Core Formulary

The IHS National Core Formulary represents the basic standard of care drugs which must be carried by all federal facilities to generally promote the parity, portability, quality, safety, convenience, and cost-effectiveness of the pharmacy benefit.

  • It establishes the "floor" for the pharmacy benefit.
  • Except in closed classes, facilities are expected to add other drugs to the local formulary as needed.
Last Updated: 11/10/2022
Search

Search Medications Results

The following is a list of Medications currently in the queue. 225 record(s) found.
The following is a list of Medications currently in the queue. 225 record(s) found.
MedicationPharmacological CategoryFormulary BriefNotesSimilar Medications
Ondansetron Antiemetic; Selective 5-HT3 Receptor Antagonist Antiemetic Agents (2021)
Metronidazole, oral Antibiotic, Miscellaneous 2021 CDC Guidelines for Sexually Transmitted Infections (2021) Tinidazole
Tinidazole Antibiotic, Miscellaneous 2021 CDC Guidelines for Sexually Transmitted Infections (2021) Metronidazole
Valacyclovir Antiviral Agent, Oral 2021 CDC Guidelines for Sexually Transmitted Infections (2021)
Amoxicillin Antibiotic, Penicillin Outpatient Abx Stewardship & URIs (2021) Pediatric and Adult oral formulations Amoxicillin and Clavulanate; Penicillin G benzathine; Penicllin V potassium
Amoxicillin and Clavulanate Antibiotic, Penicillin Outpatient Abx Stewardship & URIs (2021) Pediatric and Adult oral formulations Amoxicillin; Penicillin G benzathine; Penicllin V potassium
Cefdinir Antibiotic, Cephalosporin (Third Generation) Outpatient Abx Stewardship & URIs (2021) Pediatric and Adult oral formulations Cefixime; Ceftriaxone Injection; Cephalexin
Cephalexin Antibiotic, Cephalosporin (First Generation) Outpatient Abx Stewardship & URIs (2021) Pediatric and Adult oral formulations Cefdinir; Cefixime; Ceftriaxone Injection
Clindamycin Antibiotic, Lincosamide Outpatient Abx Stewardship & URIs (2021) Pediatric and Adult oral formulations
Penicllin V potassium Antibiotic, Penicillin Outpatient Abx Stewardship & URIs (2021) Pediatric and Adult oral formulations Amoxicillin; Amoxicillin and Clavulanate; Penicillin G benzathine
Benzoyl Peroxide Topical Skin Product, Acne Acne Treatment (2020) Benzoyl Peroxide AND Clindamycin, topical combination
Benzoyl Peroxide AND Clindamycin, topical combination Topical Skin Product, Acne; Topical Skin Product, Acne (Lincosamide Antibiotic) Acne Treatment (2020) Benzoyl Peroxide
Tretinoin, topical Topical Skin Product, Acne Treatment of Acne vulgaris (2020) *Any product*
Serotonin 5-HT1 agonist (Triptan) Antimigraine Agent; Serotonin 5-HT 1B/1D Receptor Agonist Acute Migraine (2021) Any two (2) triptan medications are required, one must be sumatriptan Sumatriptan
Sumatriptan Antimigraine Agent; Serotonin 5-HT 1B/1D Receptor Agonist Acute Migraine (2021) Any two (2) triptan medications are required, one must be sumatriptan
Methylphenidate (immediate release) Central Nervous System Stimulant ADHD (Jan 2020) Pediatric use only Methylphenidate (long-acting)
Methylphenidate (long-acting) Central Nervous System Stimulant ADHD (Jan 2020) Pediatric use only Methylphenidate (immediate release)
Dextroamphetamine / Amphetamine (immediate release) Central Nervous System Stimulant ADHD (Jan 2020) Pediatric use only
Dextroamphetamine / Amphetamine (long-acting) Central Nervous System Stimulant ADHD (Jan 2020) Pediatric use only
Atomoxetine Norepinephrine Reuptake Inhibitor, Selective ADHD (Jan 2020) Dextroamphetamine / Amphetamine (immediate release); Dextroamphetamine / Amphetamine (long-acting); Methylphenidate (immediate release); Methylphenidate (long-acting)
Naltrexone, oral Antidote; Opioid Antagonist Alcohol Use Disorder (2022) Naloxone
Topiramate Anticonvulsant, Miscellaneous Alcohol Use Disorder (2022) Carbamazepine; Divalproex; Lamotrigine; Levetiracetam; Phenytoin
H1 Antagonist (2nd generation), long-acting Histamine H1 Antagonist, Second Generation Allergic Rhinitis (2018) *Any product*
Corticosteroid, intranasal Intranasal Corticosteroid Allergic Rhinitis (2018) *Any product*
Corticosteroids (Topical) - High Potency (Class I and II) Topical Corticosteroids Alopecia Areata (2022) Corticosteroid (Topical) - Intermediate Potency; Corticosteroid (Topical) - Low Potency
Lorazepam Benzodiazepine Alcohol Withdrawal Syndrome (2015) Clonazepam
Donepezil Acetylcholinesterase Inhibitor (Central) Alzheimer's disease (2019) 5mg and 10mg strengths
Memantine N-Methyl-D-Aspartate (NMDA) Receptor Antagonist Alzheimer's disease (2019)
Oxybutynin, extended-release Antispasmodic Agent, Urinary Antimuscarinics (2019) Oxybutynin, Immediate-release
Oxybutynin, immediate-release Antispasmodic Agent, Urinary Antimuscarinics (2019) Oxybutynin, extended-release
Clopidogrel Antiplatelet Agent Antiplatelets (2015) Aspirin
Clonazepam Benzodiazepine Antiseizure Drugs (2021) Lorazepam
Levetiracetam Anticonvulsant, Miscellaneous Antiseizure Drugs (2021) Carbamazepine; Divalproex; Lamotrigine; Phenytoin; Topiramate
Gabapentin Anticonvulsant, Miscellaneous; GABA Analog Antiseizure Drugs (2021)
Phenytoin Anticonvulsant, Hydantoin Antiseizure Drugs (2021) Carbamazepine; Divalproex; Lamotrigine; Levetiracetam; Topiramate
Ethosuximide Anticonvulsant, Succinimide Anti-Seizure Drugs (2021) Carbamazepine; Clonazepam; Divalproex; Gabapentin; Lamotrigine; Levetiracetam; Phenytoin; Topiramate
Hydroxyzine Histamine H1 Antagonist, First Generation Anxiety Disorders (2021)
Mometasone (Asmanex®) Corticosteroid, Inhalant Asthma & COPD Guidelines Review (2019) *Branded product*
Montelukast Leukotriene Receptor Antagonist Asthma & COPD Guidelines Review (2019)
Albuterol, metered dose inhaler (MDI) Beta2 Agonist Asthma & COPD Guidelines Review (2019) *Any product*
Albuterol nebulized solution Beta2 Agonist Asthma & COPD Guidelines Review (2019)
Corticosteroid (Topical) - Intermediate Potency Topical Corticosteroids Atopic Dermatitis (2020) *Any product* Corticosteroid (Topical) - Low Potency
Corticosteroid (Topical) - Low Potency Topical Corticosteroids Atopic Dermatitis (2020) *Any product* Corticosteroid (Topical) - Intermediate Potency
Prednisone Corticosteroid, Systemic Atopic Dermatitis (2020)
Moisturizers (both cream- AND petroleum-based) Skin and Mucous Membrane Agent, Miscellaneous; Topical Skin Product Atopic Dermatitis (2020) Corticosteriods (Topical) - High potency (Class I and II); Corticosteroid (Topical) - Intermediate potency; Corticosteroid (Topical) - Low potency; Tacrolimus
Tacrolimus, topical Calcineurin Inhibitor; Immunosuppressant Agent; Topical Skin Product Atopic Dermatitis (2020) Corticosteriods (Topical) - High Potency (Class I and II); Corticosteroid (Topical) - Intermediate Potency; Corticosteroid (Topical) - Low Potency; Moisturizers (both cream- AND petroleum-based)
Citalopram Antidepressant, Selective Serotonin Reuptake Inhibitor Bipolar Disorder (2022) Escitalopram; Fluoxetine; Paroxetine; Sertraline
Escitalopram Antidepressant, Selective Serotonin Reuptake Inhibitor Bipolar Disorder (2022) Citalopram; Fluoxetine; Paroxetine; Sertraline
Paroxetine Antidepressant, Selective Serotonin Reuptake Inhibitor Bipolar Disorder (2022) Citalopram; Escitalopram; Fluoxetine; Sertraline
Oxcarbazepine Anticonvulsant, Miscellaneous Bipolar Disorder (2022) Carbamazepine; Clonazepam; Divalproex; Gabapentin; Lamotrigine; Levetiracetam; Phenytoin; Topiramate
Nortriptyline Antidepressant, Tricyclic Bipolar Disorder (2022) Amitriptyline
Lithium Antimanic Agent Bipolar Disorder (2022)
Duloxetine Antidepressant, Serotonin/Norepinephrine Reuptake Inhibitor/Antagonist Bipolar Disorder (2022) Bupropion; Venlafaxine
Venlafaxine Antidepressant, Serotonin/Norepinephrine Reuptake Inhibitor/Antagonist Bipolar Disorder (2022) Bupropion; Duloxetine
Sertraline Antidepressant, Selective Serotonin Reuptake Inhibitor Bipolar Disorder (2022) Citalopram; Escitalopram; Fluoxetine; Paroxetine
Amitriptyline Antidepressant, Tricyclic Bipolar Disorder (2022) Nortriptyline
Carbamazepine Anticonvulsant, Miscellaneous Bipolar Disorder (2022) Divalproex; Lamotrigine; Levetiracetam; Phenytoin; Topiramate
Fluoxetine Antidepressant, Selective Serotonin Reuptake Inhibitor Bipolar Disorder (2022) Sertraline
Divalproex Anticonvulsant, Miscellaneous Bipolar Disorder (2022) Carbamazepine; Lamotrigine; Levetiracetam; Phenytoin; Topiramate
Lamotrigine Anticonvulsant, Miscellaneous Bipolar Disorder (2022) Carbamazepine; Divalproex; Levetiracetam; Phenytoin; Topiramate
Atypical antipsychotic Antipsychotic, Atypical Bipolar Disorders (2022) *Any product* Aripiprazole lauroxil; Haloperidol decanoate
Doxazosin Alpha1 Blocker; Antihypertensive Benign Prostatic Hypertrophy (Nov 2022) Prazosin; Tamsulosin
Finasteride 5 Alpha-Reductase Inhibitor Benign Prostatic Hypertrophy (Nov 2022)
Tamsulosin Alpha1 Blocker Benign Prostatic Hypertrophy (Nov 2022) Doxazosin; Prazosin
Ulipristal Contraceptive; Progestin Receptor Modulator Contraception (2016) Levonorgestrel (Plan B One-Step®)
Medroxyprogesterone acetate, injection Contraceptive, Progestin (Injection/Depot) Contraception (2016) Medroxyprogesterone, oral; Oral contraceptive pill, progestin only
Oral contraceptive pill, extended cycle Contraceptive Contraception (2016) *Any product*
Oral contraceptive pill, monophasic: 20mcg EE (low) Contraceptive Contraception (2016) *Any product*
Oral contraceptive pill, monophasic: 30-35mcg EE (medium) Contraceptive Contraception (2016) *Any product*
Oral contraceptive pill, progestin only Contraceptive Contraception (2016) *Any product*
Oral contraceptive pill, triphasic Contraceptive Contraception (2016) *Any product*
Ethinyl estradiol / Etonogestrel vaginal ring Contraceptive; Estrogen and Progestin Combination Contraception (2016)
Ethinyl estradiol / Norelgestromin, transdermal Contraceptive; Estrogen and Progestin Combination Contraception (2016)
Levonorgestrel (Plan B One-Step®) Contraceptive, Progestin Contraception (2016) *Branded product* Ulipristal
Sulfasalazine 5-Aminosalicylic Acid Derivative Inflammatory Bowel Disease (2018) Hydroxychloroquine; Leflunomide; Methotrexate
Metformin Antidiabetic Agent; Biguanide Diabetes Treatment Overview (2017)
Insulin NPH (NovoLIN® N) Insulin, Intermediate-Acting Diabetes Treatment Overview (2017) *Branded product*
Insulin NPH / Regular human insulin (NovoLIN® 70/30) Insulin, Combination (70/30 Mix) Diabetes Treatment Overview (2017) *Branded product*
Insulin Regular human (NovoLIN® R) Insulin, Short-Acting Diabetes Treatment Overview (2017) *Branded product*
Glipizide Antidiabetic Agent; Sulfonylurea Diabetes Treatment Overview (2017)
Insulin aspart (NovoLog®) Insulin, Rapid-Acting Diabetes Treatment Overview (2017) *Branded product*; Pen Device
Insulin aspart / Insulin aspart protamine (NovoLog® Mix 70/30) Insulin, Combination (70/30 Mix) Diabetes Treatment Overview (2017) *Branded product*; Pen Device
Warfarin Anticoagulant; Vitamin K Antagonist Direct Oral Anticoagulants (2017) Apixaban; Low-molecular weight heparin
Apixaban Anticoagulant; Direct Oral Anticoagulant (DOAC); Factor Xa Inhibitor Direct Oral Anticoagulants (2017) Warfarin
Alogliptin Antidiabetic Agent, Dipeptidyl Peptidase 4 (DPP-4) Inhibitor DPP-IV Inhibitors (2019)
Varenicline Partial Nicotine Agonist, Smoking Cessation Aid Nicotine Dependence (2020) Bupropion
Nicotine replacement therapy (NRT), combination Smoking Cessation Aid Nicotine Dependence (2020) Combination NRT (nicotine patches + any short-acting NRT product) Bupropion; Varenicline
Epinephrine Injection Devices (both 0.15mg and 0.3mg) Alpha-/Beta- Agonist Epinephrine Injection Devices (2020 Any device, auto-injector or pre-filled syringe
Estradiol, transdermal Estrogen Derivative Gender Affirming Therapies (2022) *Any patch* Estradiol for Injection; Estradiol tablets
Estradiol for Injection Estrogen Derivative Gender Affirming Therapies (2022) Either valerate or cypionate product Estradiol tablets; Estradiol, transdermal
Estradiol tablets Estrogen Derivative Gender-Affirming Medications (2022) Estradiol for Injection; Estradiol, transdermal
Ciprofloxacin, ophthalmic solution Antibiotic, Ophthalmic Fluoroquinolone Ocular Treatments (2022) Artificial Tear substitute, ophthalmic (preservative free); Corticosteroid (Ophthalmic) - Low Potency; Polymyxin B/trimethoprim, Ophthalmic Solution
Proton Pump Inhibitor Proton Pump Inhibitor GERD & PUD (2018) *Any product*
Liraglutide -or- Semaglutide Antidiabetic Agent, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist GLP-1 Receptor Agonists (2019) Select either of these subcutaneous agents, no preference given
Glucose, oral Antidote Glucagon Products Review (2021) Any formulation Glucagon
Glucagon Antidote; Hypoglycemia Glucagon Products Review (2021) For outpatient use
Allopurinol Antigout Agent; Xanthine Oxidase Inhibitor Gout (2016)
Ciprofloxacin, oral Antibiotic, Fluoroquinolone Male Genitourinary Infections (Nov 2022)
Clotrimazole, topical Antifungal Agent, Imidazole Derivative Male Genitourinary Infections (Nov 2022)
Fluconazole, oral Antifungal Agent, Azole Derivative Male Genitourinary Infections (Nov 2022)
Glecaprevir/Pibrentasvir (Mavyret®) Antihepaciviral HCV Treatment (2018) Ledipasvir/sofosbuvir (Harvoni®); Sofosbuvir/velpatasvir (Epclusa®)
Ledipasvir/Sofosbuvir (Harvoni®) Antihepaciviral HCV Treatment (2018) Glecaprevir/Pibrentasvir (Mavyret®); Sofosbuvir/velpatasvir (Epclusa®)
Sofosbuvir/Velpatasvir (Epclusa®) Antihepaciviral HCV Treatment (2018) Glecaprevir/Pibrentasvir (Mavyret®); Ledipasvir/Sofosbuvir (Harvoni®)
Furosemide Antihypertensive Heart Failure with Preserved Ejection Fraction (HFpEF) (2022)
Torsemide -OR- Bumetanide Antihypertensive Heart Failure with Preserved Ejection Fraction (HFpEF) (2022) Bumetanide -OR- Torsemide; Furosemide
Bumetanide -OR- Torsemide Antihypertensive Heart Failure with Preserved Ejection Fraction (HFpEF) (2022) Furosemide; Torsemide -OR- Bumetanide
Sacubitril and Valsrtan Angiotensin II Receptor Blocker; Neprilysin Inhibitor Heart Failure with Reduced Ejection Fraction (HFrEF) (2022)
Metoprolol tartrate Antihypertensive; Beta-Blocker, Beta1 Selective Heart Failure with Reduced Ejection Fraction (HFrEF) (2022) Atenolol; Carvedilol, immediate-release; Metoprolol succinate
Empagliflozin Antidiabetic Agent, Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Heart Failure with Reduced Ejection Fraction (HFrEF) (2022)
Carvedilol, immediate-release Antihypertensive; Beta-Blocker with Alpha-Blocking Activity Heart Failure with Reduced Ejection Fraction (HFrEF) (2022) Atenolol; Propranolol
Digoxin Antiarrhythmic Agent, Miscellaneous; Cardiac Glycoside Heart Failure with Reduced Ejection Fraction (HFrEF) (2022)
Spironolactone Antihypertensive; Mineralocorticoid Receptor Antagonists; Potassium Sparing Diuretic Heart Failure with Reduced Ejection Fraction (HFrEF) (2022)
Metoprolol succinate Antihypertensive; Beta-Blocker, Beta1 Selective Heart Failure with Reduced Ejection Fraction (HFrEF) (2022) Atenolol; Carvedilol, immediate-release; Propranolol
Lactulose Ammonium Detoxicant; Laxative, Osmotic Hepatic Encephalopathy (2020) Polyethylene glycol
Rifaximin Antibiotic, Rifamycin Hepatic Encephalopathy (2020) After failure of, or intolerance to, lactulose monotherapy as indicated for hepatic encephalopathy Lactulose
Dolutegravir Antiretroviral, Integrase Inhibitor (Anti-HIV) HIV Updates (2020) For HIV treatment in pregnant patients Emtricitabine/tenofovir disoproxil fumarate; Raltegravir
Emtricitabine/Tenofovir disoproxil fumarate Antiretroviral, Reverse Transcriptase Inhibitor, Nucleoside (Anti-HIV); Antiretroviral, Reverse Transcriptase Inhibitor, Nucleotide (Anti-HIV) HIV Pre-Exposure Prophylaxis (PrEP) (2018) For (1) Pre-Exposure HIV Prophylaxis, (2) Post-Exposure HIV Prophylaxis (with raltegravir) or (3) HIV Treatment (with raltegravir) in patients with contraindications for 1st line anti-HIV agents Raltegravir
Raltegravir Antiretroviral, Integrase Inhibitor (Anti-HIV) HIV Treatment (2019) For (1) HIV Post-Exposure Prophylaxis (with emtricitabine/ tenofovir DF) or (2) HIV Treatment (with emtricitabine/tenofovir DF) in patients with contraindications for 1st line anti-HIV agents Emtricitabine/tenofovir disoproxil fumarate
Bictegravir/Emtricitabine/Tenofovir alafenamide Antiretroviral, Integrase Inhibitor (Anti-HIV) HIV Treatment (2019) Dolutegravir/abacavir/lamivudine; Emtricitabine/tenofovir disoproxil fumarate; Raltegravir
Dolutegravir/Abacavir/Lamivudine Antiretroviral, Integrase Inhibitor (Anti-HIV) HIV Treatment (2019) *Note: HLA B5701 testing required prior to initiation Bictegravir/Emtricitabine/Tenofovir alafenamide; Dolutegravir; Emtricitabine/tenofovir disoproxil fumarate; Raltegravir
Ezetimibe Antilipemic Agent, 2-Azetidinone Hyperlipidemia (2022)
Rosuvastatin Antilipemic Agent, HMG-CoA Reductase Inhibitor Hyperlipidemia (2022) Atorvastatin; Pravastatin; Simvastatin
Pravastatin Antilipemic Agent, HMG-CoA Reductase Inhibitor Hyperlipidemia (2022) Atorvastatin; Rosuvastatin; Simvastatin
Simvastatin Antilipemic Agent, HMG-CoA Reductase Inhibitor Hyperlipidemia (2022) Atorvastatin; Pravastatin; Rosuvastatin
Atorvastatin Antilipemic Agent, HMG-CoA Reductase Inhibitor Hyperlipidemia (2022) Pravastatin; Rosuvastatin; Simvastatin
Atenolol Antihypertensive; Beta-Blocker, Beta1 Selective Hypertension (2022) Propranolol
Chlorthalidone Antihypertensive; Thiazide-Related Diuretic Hypertension (2022) Hydrochlorothiazide
Amlodipine Antihypertensive; Calcium Channel Blocker, Dihydropyridine Hypertension (2022) Diltiazem
Diltiazem Antihypertensive; Calcium Channel Blocker, Nondihydropyridine Hypertension (2022) Amlodipine
Lisinopril Antihypertensive, Angiotensin-Converting Enzyme Inhibitor Hypertension (2022)
Losartan Antihypertensive, Angiotensin II Receptor Blocker Hypertension (2022)
Hydrochlorothiazide Antihypertensive; Thiazide Diuretic Hypertension (2022) Chlorthalidone
Methimazole Antithyroid Agent; Thioamide Hyperthyroidism (2021) Propylthiouracil
Propylthiouracil Antithyroid Agent; Thioamide Hyperthyroidism (2021) Methimazole
Oseltamivir Antiviral Agent; Neuraminidase Inhibitor Treatment of Influenza (2019)
Pramipexole Anti-Parkinson Agent, Dopamine Agonist Insomnia/Sleep Medications (2021)
Polyethylene glycol Laxative, Osmotic Irritable Bowel Syndrome (2018) *Any product* Lactulose
Loperamide Antidiarrheal Irritable Bowel Syndrome (2018)
Dicyclomine Anticholinergic Agent Irritable Bowel Syndrome (2018)
Fluticasone/Salmeterol Beta2 Agonist, Long-Acting; Corticosteroid, Inhalant LABAs (2019) Mometasone (Asmanex®)
Insulin glargine, any Insulin, Long-Acting Long-Acting Insulins & Biosimilars (2021) An interchangeable biosimilar product is a biosimilar that meets additional requirements outlined by the law that allows for the FDA to approve biosimilar and interchangeable biosimilar medications. Insulin detemir (Levemir®)
Insulin detemir (Levemir®) Insulin, Long-Acting Long-acting Insulins & Biosimilars (2021) *Branded product*; Pen Device
Umeclidinium/Vilanterol Long-Acting Muscarinic Antagonist (LAMA) / Long-Acting Beta2 Agonist (LABA) LAMAs (2019) Tiotropium (Spiriva®)
Tiotropium (Spiriva®) Long-Acting Anticholinergic Agent Long Acting Muscarinic Antagonists (2019) *Branded product*
Aripiprazole lauroxil Antipsychotic, Atypical (Second Generation) - Injectable Long-Acting Injectable Antipsychotics (2020) Injectable Haloperidol decanoate
Haloperidol decanoate Antipsychotic, Typical (First Generation) - Injectable Long-Acting Injectable Antipsychotics (2020) Injectable Aripiprazole lauroxil
Intrauterine device, copper Contraceptive Long Acting Reversible Contraception (2021) *Any product*; For use by a skilled and privileged provider Intrauterine device, levonorgestrel
Intrauterine device, levonorgestrel Contraceptive, Progestin Long Acting Reversible Contraception (2021) *Any product*; For use by a skilled and privileged provider Intrauterine device, copper
Etonogestrel, implant Contraceptive; Progestin Long Acting Reversible Contraception (2021) For use by a skilled and privileged provider Oral contraceptive pill, progestin only
Testosterone (**REMS Drug**) Androgen Male Hypogonadism (2022) Any formulation; Certain formulations (i.e., undecoanate) have REMS requirements Exit Disclaimer: You Are Leaving www.ihs.gov 
Buprenorphine, short-acting (**REMS drug**) Analgesic, Opioid; Analgesic, Opioid Partial Agonist MAT for OUD (2021) Any formulation; Restricted to treatment of Opioid Use Disorder; **See REMS here** Exit Disclaimer: You Are Leaving www.ihs.gov  Buprenorphine, long-acting (**REMS drug**); Buprenorphine-Naloxone (**REMS drug**)
Buprenorphine, long-acting (**REMS drug**) Analgesic, Opioid; Analgesic, Opioid Partial Agonist MAT for OUD (2021) Any formulation; Restricted to treatment of Opioid Use Disorder; **See REMS here** Exit Disclaimer: You Are Leaving www.ihs.gov  Buprenorphine, short-acting (**REMS drug**); Buprenorphine-Naloxone (**REMS drug**)
Buprenorphine-Naloxone (**REMS drug**) Analgesic, Opioid; Analgesic, Opioid Partial Agonist MAT for OUD (2021) **See REMS here** Exit Disclaimer: You Are Leaving www.ihs.gov  Naloxone
Propranolol Antihypertensive; Beta-Blocker, Non-Selective Migraine Prevention (2019) Atenolol
Methotrexate Antineoplastic Agent; Antirheumatic; Disease Modifying; Immunosuppresant Agent Non-biologic DMARDs (2016) Hydroxychloroquine; Leflunomide; Sulfasalazine
Hydroxychloroquine Antimalarial Non-biologic DMARDs (2016) Leflunomide; Methotrexate; Sulfasalazine
Leflunomide Antirheumatic, Disease Modifying Non-biologic DMARDs (2016) Hydroxychloroquine; Methotrexate; Sulfasalazine
Ibuprofen Nonsteroidal Anti-Inflammatory Drug NSAIDs (2014) Diclofenac; Indomethacin; Meloxicam; Naproxen
Indomethacin Nonsteroidal Anti-Inflammatory Drug NSAIDs (2014) Diclofenac; Ibuprofen; Meloxicam; Naproxen
Diclofenac Nonsteroidal Anti-Inflammatory Drug NSAIDs (2014) *Any formulation* Ibuprofen; Indomethacin; Meloxicam; Naproxen
Meloxicam Nonsteroidal Anti-Inflammatory Drug NSAIDs (2014) Diclofenac; Ibuprofen; Indomethacin; Naproxen
Naproxen Nonsteroidal Anti-Inflammatory Drug NSAIDs (2014) Diclofenac; Ibuprofen; Indomethacin
Cyanocobalamin (Vitamin B12), oral Vitamin, Water Soluble Hematologic Supplements (2016)
Isoniazid Antitubercular Agent Treatment of Tuberculosis (2021) Ethambutol; Pyrazinamide; Rifampin; Rifapentine
Fluoride, oral Nutritional Supplement Supplements in Oral Health (2016) *Any oral formulation*
Semaglutide -or- Liraglutide Antidiabetic Agent, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Long-term Pharmacotherapy for the Patient with Overweight or Obesity (2022) Select either of these subcutaneous agents, no preference given
Phentermine and Topiramate ER (**REMS drug**) Anticonvulsant, Miscellaneous; Central Nervous System Stimulant Obesity Management (2022) **For REMS criteria, see Formulary Brief**
Polymyxin B/Trimethoprim, ophthalmic solution Antibiotic, Ophthalmic Ocular Treatments (2022) Artificial Tear substitute, ophthalmic (preservative free); Ciprofloxacin, ophthalmic solution; Corticosteroid (Ophthalmic) - Low Potency
Corticosteroid (Ophthalmic) - Low Potency Corticosteroid, Ophthalmic Ocular Treatments (2022) *Any product - see Form Brief for suggested products Artificial Tear substitute, Ophthalmic (Preservative Free); Ciprofloxacin, Ophthalmic Solution; Polymyxin B/trimethoprim, Ophthalmic Solution; Prednisolone, Ophthalmic Suspension
Prednisolone acetate, ophthalmic suspension Corticosteroid, Ophthalmic Ocular Treatments (2022) Artificial Tear substitute, ophthalmic (preservative free); Ciprofloxacin, ophthalmic solution; Corticosteroid (Ophthalmic) - Low Potency; Polymyxin B/Trimethoprim, ophthalmic solution
Artificial Tear substitute, ophthalmic (preservative free) Ophthalmic Agent, Miscellaneous Ocular Treatments (2022) *Any Preservative-Free product* Ciprofloxacin, Ophthalmic Solution; Corticosteroid (Ophthalmic) - Low Potency; Polymyxin B/trimethoprim, Ophthalmic Solution
Ophthalmic Prostaglandin Analog Ophthalmic Prostaglandin Analog Ophth Prostaglandin Analogs (2018) *Any product*
Naloxone Antidote; Opioid Antagonist Opioid Use Disorder (2018)
Naltrexone, extended-release for injection Antidote; Opioid Antagonist Opioid Use Disorder (2018)
Alendronate Bisphosphonate Derivative Osteoporosis (2016)
Calcium Electrolyte Supplement Osteoporosis (2016) *Any formulation*
Carbidopa-Levodopa, immediate-release Anti-Parkinson Agent; Decarboxylase Inhibitor-Dopamine Precursor Parkinson's Disease (2019)
Sevelamer carbonate Phosphate Binder Phosphate Binders (2018) For patients on dialysis who cannot use calcium-based phosphate binders due to hypercalcemia Calcium
Medroxyprogesterone, oral Contraceptive; Progestin Polycystic Ovarian Syndrome (2017) Medroxyprogesterone acetate, injection; Oral contraceptive pill, progestin only
Vitamin D Vitamin D Analog Pregnancy & Prenatal Care (2021) *Any product*
Pyridoxine (Vitamin B6) Vitamin, Water Soluble Pregnancy & Prenatal Care (2021)
Aspirin Antiplatelet Agent; Nonsteroidal Anti-Inflammatory Drug; Salicylate Pregnancy & Prenatal Care (2021)
Folic Acid Vitamin, Water Soluble Pregnancy & Prenatal Care (2021) Any product containing >400 mcg / daily dose
Iron, oral Iron Salt Pregnancy & Prenatal Care (2021) *Any oral formulation*
Prenatal Multivitamin Vitamin Pregnancy & Prenatal Care (2021) Must contain >400 mcg of folic acid/dose
Leuprolide Antineoplastic Agent, Gonadotropin-Releasing Hormone Agonist Treatment of Prostate Cancer (Nov 2022) **Any depot form**
Vitamin D Analog, topical Vitamin D Analog Psoriasis (2018) *Any product*
Prazosin Alpha1 Blocker; Antihypertensive Post Traumatic Stress Disorder (2021) Doxazosin; Tamsulosin
Metronidazole, topical Antibiotic, Topical Rosacea (2022)
Sunscreen, Sun Protection Factor (SPF) 30 or greater Ultraviolet light protectant, topical Rosacea Treatment (2022)
Acetaminophen Analgesic, Miscellaneous Short-Acting Opioids (2014)
Ceftriaxone, injection Antibiotic, Cephalosporin (Third Generation) STIs - PART 1 (2021) Cefdinir; Cefixime; Cephalexin
Cefixime Antibiotic, Cephalosporin (Third Generation) STIs - PART 1 (2021) For outpatient treatment of gonorrhea for Expedited Partner Therapy or when injection therapy is not possible Cefdinir; Ceftriaxone Injection; Cephalexin
Azithromycin Antibiotic, Macrolide STIs - PART 1 (2021)
Doxycycline Antibiotic, Tetracycline STIs - PART 1 (2021)
Penicillin G benzathine Antibiotic, Penicillin STIs - PART 1 (2021) Amoxicillin; Amoxicillin and Clavulanate; Penicllin V potassium
Mupirocin Antibiotic, Topical Skin & Soft Tissue Infections (2021)
Trimethoprim-Sulfamethoxazole Antibiotic, Miscellaneous Skin & Soft Tissue Infections (2021)
Bupropion Antidepressant, Dopamine/Norepinephrine-Reuptake Inhibitor; Smoking Cessation Aid Stimulant Use Disorder (2022) Varenicline; Venlafaxine
Permethrin 5% cream Antiparasitic Agent, Topical; Pediculocide; Scabicidal Agent Sexually Transmitted Infections, Part III (2022) Permethrin 1%, any formulation
Permethrin 1% Antiparasitic Agent, Topical; Pediculocide; Scabicidal Agent Sexually Transmitted Infections, Part III (2022) *Any formulation* Permethrin 5% cream
Pioglitazone Antidiabetic Agent, Thiazolidinedione Thiazolidinediones (2017)
Adalimumab -OR- Etanercept (can choose either product) Antirheumatic, Disease Modifying; Tumor Necrosis Factor (TNF) Blocking Agent TNF Inhibitors (2016) ONLY In consultation with a rheumatologist Etanercept -OR- Adalimumab (can choose either product)
Etanercept -OR- Adalimumab (can choose either product) Antirheumatic, Disease Modifying; Tumor Necrosis Factor (TNF) Blocking Agent TNF Inhibitors (2016) ONLY In consultation with a rheumatologist Adalimumab -OR- Etanercept (can choose either product)
Ethambutol Antitubercular Agent Treatment of Tuberculosis (2021) Isoniazid; Pyrazinamide; Rifampin; Rifapentine
Pyrazinamide Antitubercular Agent Treatment of Tuberculosis (2021) Ethambutol; Isoniazid; Rifampin
Rifampin Antitubercular Agent Treatment of Tuberculosis (2021) Ethambutol; Isoniazid; Pyrazinamide; Rifapentine
Rifapentine Antitubercular Agent Treatment of Tuberculosis (2021) Ethambutol; Isoniazid; Pyrazinamide; Rifampin
Nitrofurantoin Antibiotic, Miscellaneous Urinary Tract Infections (2021)
Vaccines, All ACIP-recommended Vaccines Vaccine (2011) All ACIP recommended vaccines for routine use in accordance with ACIP guidelines
Low-molecular weight heparin Low-molecular Weight Heparin VTE Prophylaxis (2011) *Any product*
Sildenafil Phosphodiesterase-5 Enzyme Inhibitor Erectile Dysfunction (Nov 2022) Tadalafil
Tadalafil Phosphodiesterase-5 Enzyme Inhibitor Erectile Dysfunction (Nov 2022) Sildenafil
Letrozole Antineoplastic Agent, Aromatase Inhibitor NPTC Update Spring 2021
Anastrozole Antineoplastic Agent, Aromatase Inhibitor NPTC Update Spring 2021
Tamoxifen Antineoplastic Agent, Estrogen Receptor Antagonist; Selective Estrogen Receptor Modulator NPTC Update Spring 2021
Estrogen vaginal cream Estrogen Derivative NPTC Meeting Update (May 2018) *Any product* Estradiol tablets
Famotidine Histamine H2 Antagonist Fall 2022 NPTC Meeting Update
Laxative, stimulant Stimulant Laxative Added July 2011 (Constipation) *Any product*
Laxative, bulk-forming Bulk-forming Laxative Added July 2011 (Constipation) *Any product*
Salsalate Salicylate Added June 2008 (NSAIDs)
Nitroglycerin 0.4 milligrams, sublingual Antianginal Agent; Antidote, Extravasation; Vasodilator Anti-Anginal Treatment (2013) Isosorbide mononitrate; Nitroglycerin patch
Nitroglycerin patch Antianginal Agent; Antidote, Extravasation; Vasodilator Anti-Anginal Treatment (2013) Isosorbide mononitrate
Isosorbide mononitrate Antianginal Agent; Vasodilator Anti-Anginal Treatment (2013) Nitroglycerin patch
Levothyroxine Thyroid Agent Originally added 2004